Quick Answer
Travere Therapeutics, Inc. reported Common Stock Shares Outstanding of 90.92 million shares for the year ending 2025.
- Travere Therapeutics, Inc. showed an increase of +4.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Travere Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Travere Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 2,149.3%.
- Historical annual values: Fiscal year 2025: 90.92 million shares | Fiscal year 2024: 87.45 million shares | Fiscal year 2023: 75.37 million shares | Fiscal year 2022: 64.29 million shares | Fiscal year 2021: 62.49 million shares | Fiscal year 2020: 52.25 million shares | Fiscal year 2019: 43.09 million shares | Fiscal year 2018: 41.39 million shares | Fiscal year 2017: 39.37 million shares | Fiscal year 2016: 37.91 million shares | Fiscal year 2015: 36.47 million shares | Fiscal year 2014: 26.05 million shares | Fiscal year 2013: 18.42 million shares | Fiscal year 2012: 8.95 million shares | Fiscal year 2011: 4.04 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: